Compare LCTX & TSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LCTX | TSBK |
|---|---|---|
| Founded | 1990 | 1915 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 366.2M | 306.8M |
| IPO Year | 1996 | 1997 |
| Metric | LCTX | TSBK |
|---|---|---|
| Price | $1.95 | $39.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.67 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 16.2K |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.96% |
| EPS Growth | ★ 25.00 | 21.93 |
| EPS | N/A | ★ 1.04 |
| Revenue | ★ $9,499,000.00 | N/A |
| Revenue This Year | $6.32 | N/A |
| Revenue Next Year | $124.49 | N/A |
| P/E Ratio | ★ N/A | $37.63 |
| Revenue Growth | ★ 6.19 | N/A |
| 52 Week Low | $0.37 | $27.51 |
| 52 Week High | $2.09 | $40.41 |
| Indicator | LCTX | TSBK |
|---|---|---|
| Relative Strength Index (RSI) | 64.30 | 59.41 |
| Support Level | $1.55 | $30.95 |
| Resistance Level | $2.04 | $40.08 |
| Average True Range (ATR) | 0.11 | 0.81 |
| MACD | 0.02 | -0.12 |
| Stochastic Oscillator | 89.04 | 62.17 |
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
Timberland Bancorp Inc is a bank holding company for Timberland Bank. The bank offers banking services including personal checking and savings accounts, debit cards, health savings accounts, online and mobile banking, online bill pay, 24-hour phone banking, and Zelle. Business services include business checking accounts, online banking, remote deposit, ACH transactions, Autobooks, and insured cash sweep services. The bank also provides lending services such as personal credit cards, home loans, home equity borrowing, construction loans, and SBA loans. In addition, it offers loans to real estate, including residential and commercial real estate, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.